메디톡스, 대한항노화학회서 필러·톡신 기술력 입증
Predicted impact: Low
Dividend of KRW 1,200 per share already announced; this news is only conference promotion.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.